Henry Schein, Inc. (hsic)
HSIC — Company Overview
Investors tracking HSIC follow a Medical Distribution name listed on NMS within Healthcare.
| Ticker | HSIC |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Exchange | NMS |
| Market cap | $9.48B |
| Last price | $85.05 |
| Size category | Mid Cap |
HSIC — Business Description
The business profile of Henry Schein, Inc. (HSIC) reflects its role in Medical Distribution. Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as…
Official website: https://www.henryschein.com.
HSIC — Investment Thesis
Henry Schein, Inc. (HSIC) attracts investors weighing Medical Distribution fundamentals against current market pricing.
- Revenue is expanding at roughly 6.7% year-over-year (public data).
- Trailing P/E of 24.80× sits in a moderate band relative to high-growth peers.
- Forward P/E (14.18×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $9.48B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
HSIC — Financial Health
HSIC financial profile reflects operating efficiency and capital structure using available market fundamentals.
Profit margin near 3.0% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $446.00M supports balance-sheet flexibility.
| Trailing P/E | 24.80× |
| Forward P/E | 14.18× |
| Price / Sales | 0.71× |
| Price / Book | 3.01× |
| Gross margin | 31.3% |
| Operating margin | 5.8% |
| Profit margin | 3.0% |
| Return on equity | 8.9% |
| Debt / Equity | 80.73 |
| Free cash flow | $446.00M |
HSIC — Growth Outlook
Growth outlook for Henry Schein, Inc. (HSIC) depends on demand trends in Medical Distribution and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 6.7% suggests steady but measured expansion.
- Earnings growth of 17.1% year-over-year supports improving profitability.
- Price is 7.7% below the 52-week high.
HSIC — Competitive Position
Henry Schein, Inc. (HSIC) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Distribution.
- Market capitalization of $9.48B places HSIC among mid-cap peers.
- Gross margin of 31.3% should be benchmarked against direct competitors.
HSIC — Strengths
Strengths for Henry Schein, Inc. (HSIC) inferred from public financial metrics:
- Revenue growth of 6.7% year-over-year.
- Earnings growth of 17.1% year-over-year.
- Positive free cash flow ($446.00M).
- Price near 52-week highs — positive price momentum on public markets.
HSIC — Weaknesses
Weaknesses and pressure points for Henry Schein, Inc. (HSIC) based on available data:
- Thin profit margin (3.0%).
HSIC — Opportunities
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
HSIC — Risks
- Thin margins leave less room for operational missteps.
HSIC — Summary
Henry Schein, Inc. (HSIC) is a mid-cap Healthcare company focused on Medical Distribution, listed on NMS. Last price $85.05 with market cap $9.48B. Trailing P/E 24.80×. Revenue grew 6.7% year-over-year per public data. Notable strengths include revenue growth of 6.7% year-over-year. Key watch items include thin profit margin (3.0%). Review free estimates and earnings pages for HSIC; upgrade for institutional ownership and live headlines.
Start Free — open HSIC in Vest Terminal
Access live data, filings, ownership, and analysis for Henry Schein, Inc..
Henry Schein, Inc. FAQ
What does Henry Schein, Inc. (HSIC) do?
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Valu…
What is HSIC's P/E ratio?
Henry Schein, Inc. has a trailing P/E of 24.80× based on publicly available market data.
Does HSIC pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is HSIC in?
Henry Schein, Inc. is classified in Healthcare (Medical Distribution) on NMS.
What is HSIC's market capitalization?
Approximate market cap: $9.48B.
What are the main risks for HSIC?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of HSIC?
Potential positives include revenue growth of 6.7% year-over-year, earnings growth of 17.1% year-over-year.
Where can I get analyst estimates for HSIC?
Public analyst price targets and consensus for Henry Schein, Inc. are on the free /stocks/hsic/estimates page. Deeper estimate history and models are available in Vest Terminal.